Feist, Eugen <br/><br/>
Small molecules targeting JAKs--a new approach in the treatment of rheumatoid arthritis.  [electronic resource] 

 -  Rheumatology (Oxford, England)  Aug 2013 
 - 1352-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>1462-0332 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/kes417  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aminopyridines<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Rheumatoid--diagnosis<br/>Clinical Trials, Phase III as Topic<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Forecasting<br/>Germany<br/>Humans<br/>Janus Kinases--antagonists & inhibitors<br/>Male<br/>Maximum Tolerated Dose<br/>Molecular Targeted Therapy--methods<br/>Morpholines<br/>Oxazines--administration & dosage<br/>Piperidines--administration & dosage<br/>Prognosis<br/>Pyridines--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Pyrroles--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Severity of Illness Index<br/>Treatment Outcome